Oxidative modification of LDL is associated with plaque formation and vascular inflammation, exacerbating CHD in patients with SLE.[42,43] Dysregulation of SOD isoforms results in impaired antioxidant defence mechanisms, further amplifying oxidative stress and contributing to endothelial dysfunction[44] (Fig. 2). Here, SOD1 is linked to endothelial dysfunction.